Viemed Healthcare, Inc. (VMD) — 10-Q Filings
All 10-Q filings from Viemed Healthcare, Inc.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
Viemed's Revenue Soars 24% Amidst Aggressive Acquisition Strategy
— Nov 5, 2025 Risk: medium
Viemed Healthcare, Inc. (VMD) reported a significant increase in revenue for the nine months ended September 30, 2025, reaching $194.1 million, up from $163.6 m -
Viemed Healthcare Soars on 23% Revenue Growth
— Aug 6, 2025 Risk: medium
VIEMED HEALTHCARE, INC. reported robust financial performance for the six months ended June 30, 2025, with revenue increasing to $160.0 million from $130.0 mill -
Viemed Healthcare Files Q1 2025 10-Q
— May 7, 2025 Risk: low
Viemed Healthcare, Inc. filed its quarterly report for the period ending March 31, 2025. The company's principal executive offices are located at 625 E. Kaliste -
Viemed Healthcare Files Q3 2024 10-Q
— Nov 6, 2024 Risk: medium
Viemed Healthcare, Inc. filed its 10-Q for the period ending September 30, 2024. The filing details financial performance and operational updates for the third -
Viemed Healthcare Q2 2024: Revenue Dip, Assets $226.8M
— Aug 7, 2024 Risk: medium
For the quarter ended June 30, 2024, Viemed Healthcare, Inc. reported total assets of $226.8 million and total liabilities of $106.8 million. The company's reve -
VIEMED HEALTHCARE, INC. Files 10-Q for Period Ending March 31, 2024
— May 6, 2024 Risk: low
VIEMED HEALTHCARE, INC. (VMD) filed a Quarterly Report (10-Q) with the SEC on May 6, 2024. VIEMED HEALTHCARE, INC. filed a 10-Q report for the period ending Mar
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX